关注
Silvia Cantoni
Silvia Cantoni
Corporate Pre-clinical R&D, Chiesi Farmaceutici S.p.A., Italy
在 chiesi.com 的电子邮件经过验证
标题
引用次数
年份
Proteomic Analysis of Right Ventricular Hypertrophy in Experimental Pulmonary Arterial Hypertension and the Impact of Therapeutic Intervention
S Cantoni, B Pioselli, M Cont, ML Faietti, F Pastore, M Vilaseca, G Marina, ...
C60. BEACHCOMBING FOR GOLD:-OMICS, INFLAMMATION, AND THE RV IN PH, A6029-A6029, 2024
2024
Intrinsic Bone Morphogenetic Protein Antagonist Gremlin 1 as a Potential Biomarker for Therapy Efficacy in a Rat Model of Pulmonary Arterial Hypertension
S Cantoni, F Pastore, E Schiavi, M Cont, S Pareti, F Facchinetti
A60. LET'S MEET AT DUPONT CIRCLE: NEW MOLECULAR TRAFFIC PATTERNS IN …, 2023
2023
Echocardiographic evaluation of pharmacological antagonism of endothelin receptors in a rat model of pulmonary arterial hypertension
S Cantoni, M Cont, S Cavalli, A Fioni, A Pappani, F Pastore, G Villetti, ...
Vascular Pharmacology 132, 106706, 2020
2020
Longitudinal In Vivo Imaging by Transthoracic Four-Dimensional Echocardiography in Experimental Pulmonary Arterial Hypertension Upon Tadalafil Treatment
S Cantoni, M Cont, S Cavalli, F Pastore, A Fioni, G Villetti, F Facchinetti
A57. PULMONARY VASCULAR DISEASES AND RV FUNCTIONS: NOVEL SIGNALLING …, 2020
2020
Primary pulmonary arterial hypertension: Protocol to assess comprehensively in the rat the response to pharmacologic treatments
D Novelli, F Fumagalli, L Staszewsky, G Ristagno, D Olivari, S Masson, ...
MethodsX 7, 100771, 2020
12020
Monocrotaline-induced pulmonary arterial hypertension: Time-course of injury and comparative evaluation of macitentan and Y-27632, a Rho kinase inhibitor
D Novelli, F Fumagalli, L Staszewsky, G Ristagno, D Olivari, S Masson, ...
European Journal of Pharmacology 865, 172777, 2019
172019
Macitentan modulates pulmonary mRNA levels of gremlin 1 in a rat model of pulmonary arterial hypertension
E Schiavi, S Cantoni, G Volpi, M Cont, F Pastore, S Cavalli, F Dardi, ...
European Respiratory Journal 54 (suppl 63), 2019
2019
Pharmacological characterization of a highly selective Rho kinase (ROCK) inhibitor and its therapeutic effects in experimental pulmonary hypertension
S Cantoni, S Cavalli, F Pastore, A Accetta, D Pala, F Vaccaro, N Cesari, ...
European journal of pharmacology 850, 126-134, 2019
212019
Comparative Evaluation of Two Different Modalities of Oral Delivery of Macitentan in Experimental Pulmonary Hypertension
S Cantoni, M Cont, F Pastore, S Cavalli, F Dardi, A Fioni, M Milioli, ...
C50. THE PERFECT DRUG: EXPERIMENTAL TREATMENTS OF PAH, A5057-A5057, 2019
2019
Echocardiographyc and histomorphometric assessment of the effects of pharmacological antagonism of endothelin receptors in the Sugen 5416/hypoxia rat model of pulmonary …
S Cantoni, S Cavalli, F Pastore, R Nassini, F De Logu, G Villetti, ...
European Respiratory Journal 52 (suppl 62), 2018
2018
The selective Rho kinase inhibitor trans-6-((4-aminocyclohexyl) amino)-5-fluoro-2-methoxynicotinamide ameliorates experimental pulmonary hypertension
S Cavalli, S Cantoni, A Accetta, F Pastore, G Marchini, S Bertolini, ...
European Respiratory Journal 50 (suppl 61), 2017
12017
The selective rho kinase inhibitor trans-6-((4-aminocyclohexyl) amino)-5-fluoro-2-methoxynicotinamide ameliorates monocrotaline-induced pulmonary hypertension
S Cantoni, S Cavalli, A Accetta, F Pastore, G Marchini, S Bertolini, ...
EUROPEAN HEART JOURNAL 38, 147-147, 2017
2017
P726 The selective rho kinase inhibitor trans-6-((4-aminocyclohexyl) amino)-5-fluoro-2-methoxynicotinamide ameliorates monocrotaline-induced pulmonary hypertension
S Cantoni, S Cavalli, A Accetta, F Pastore, G Marchini, S Bertolini, ...
European Heart Journal 38 (suppl_1), ehx501. P726, 2017
2017
Hemodynamic and anti-remodelling effect of the Rho kinase inhibitor Y-27632 in the monocrotaline pulmonary arterial hypertension rat model
S Cantoni, F Pastore, S Cavalli, G Marchini, G Villetti, R Nassini, ...
European Respiratory Journal 48 (suppl 60), 2016
42016
Occurring of In Vitro Functional Vasculogenic Pericytes from Human Circulating Early Endothelial Precursor Cell Culture
S Cantoni, F Bianchi, M Galletti, E Olivi, F Alviano, N Galiè, C Ventura
Stem cells international 2015 (1), 943671, 2015
142015
Dissecting histone deacetylase role in pulmonary arterial smooth muscle cell proliferation and migration
M Galletti, S Cantoni, F Zambelli, S Valente, M Palazzini, A Manes, ...
Biochemical Pharmacology 91 (2), 181-190, 2014
292014
The role of F-18 FDG PET in the diagnosis of visceral leishmaniasis: two case reports
L Chianura, ME De Ferrari, CE Popescu, S Cantoni, G Colussi, C Rossetti, ...
Journal of Case Reports 4 (1), 20-25, 2014
12014
Leonardo Chianura1, Maria Elisabetta De Ferrari2, Cristina Elena Popescu3
S Cantoni, G Colussi, C Rossetti, M Puoti
JOURNAL OF CASE REPORTS 4 (1), 20-25, 2014
2014
Sodium butyrate inhibits platelet‐derived growth factor‐induced proliferation and migration in pulmonary artery smooth muscle cells through A kt inhibition
S Cantoni, M Galletti, F Zambelli, S Valente, F Ponti, R Tassinari, ...
The FEBS journal 280 (9), 2042-2055, 2013
502013
Development of strategies for vascular damage repair in Pulmonary Arterial Hypertension
S Cantoni
alma, 2013
2013
系统目前无法执行此操作,请稍后再试。
文章 1–20